Cargando…
Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis
BACKGROUND: Cannabis consumption by pregnant women continues to increase worldwide, raising concerns about adverse effects on fetal growth and deleterious impacts on the newborn, in connection with evidence of placental transfer of cannabis compound. Cannabis action is mediated by the endocannabinoi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334520/ https://www.ncbi.nlm.nih.gov/pubmed/37430350 http://dx.doi.org/10.1186/s12916-023-02916-5 |
_version_ | 1785070873177227264 |
---|---|
author | Dochez-Arnault, J. Desdoits-Lethimonier, C. Matias, I. Evrard, B. Lagarrigue, M. Toupin, M. Lardenois, A. Chalmel, F. Mazaud-Guittot, S. Dejucq-Rainsford, N. Gely-Pernot, A. |
author_facet | Dochez-Arnault, J. Desdoits-Lethimonier, C. Matias, I. Evrard, B. Lagarrigue, M. Toupin, M. Lardenois, A. Chalmel, F. Mazaud-Guittot, S. Dejucq-Rainsford, N. Gely-Pernot, A. |
author_sort | Dochez-Arnault, J. |
collection | PubMed |
description | BACKGROUND: Cannabis consumption by pregnant women continues to increase worldwide, raising concerns about adverse effects on fetal growth and deleterious impacts on the newborn, in connection with evidence of placental transfer of cannabis compound. Cannabis action is mediated by the endocannabinoid system (ECS), which expression is well established in the brain but unknown in the developing testis. The fetal testis, whose endocrine function orchestrates the masculinization of many distant organs, is particularly sensitive to disruption by xenobiotics. In this context, we aimed to determine whether cannabis exposure has the potential to directly impact the human fetal testis. METHODS: We determined the expression of components of the ECS in the human fetal testis from 6 to 17 developmental weeks and assessed the direct effects of phytocannabinoids Δ9-trans-tetrahydrocannabinol (THC) and cannabidiol (CBD) on the testis morphology and cell functions ex vivo. RESULTS: We demonstrate the presence in the human fetal testis of two key endocannabinoids, 2-arachidonylglycerol (2-AG) and to a lower level anandamide (AEA), as well as a range of enzymes and receptors for the ECS. Ex vivo exposure of first trimester testes to CBD, THC, or CBD/THC [ratio 1:1] at 10(−7) to 10(−5) M altered testosterone secretion by Leydig cells, AMH secretion by Sertoli cells, and impacted testicular cell proliferation and viability as early as 72 h post-exposure. Transcriptomic analysis on 72 h-exposed fetal testis explants revealed 187 differentially expressed genes (DEGs), including genes involved in steroid synthesis and toxic substance response. Depending on the molecules and testis age, highly deleterious effects of phytocannabinoid exposure were observed on testis tissue after 14 days, including Sertoli and germ cell death. CONCLUSIONS: Our study is the first to evidence the presence of the ECS in the human fetal testis and to highlight the potential adverse effect of cannabis consumption by pregnant women onto the development of the male gonad. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-023-02916-5. |
format | Online Article Text |
id | pubmed-10334520 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103345202023-07-12 Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis Dochez-Arnault, J. Desdoits-Lethimonier, C. Matias, I. Evrard, B. Lagarrigue, M. Toupin, M. Lardenois, A. Chalmel, F. Mazaud-Guittot, S. Dejucq-Rainsford, N. Gely-Pernot, A. BMC Med Research Article BACKGROUND: Cannabis consumption by pregnant women continues to increase worldwide, raising concerns about adverse effects on fetal growth and deleterious impacts on the newborn, in connection with evidence of placental transfer of cannabis compound. Cannabis action is mediated by the endocannabinoid system (ECS), which expression is well established in the brain but unknown in the developing testis. The fetal testis, whose endocrine function orchestrates the masculinization of many distant organs, is particularly sensitive to disruption by xenobiotics. In this context, we aimed to determine whether cannabis exposure has the potential to directly impact the human fetal testis. METHODS: We determined the expression of components of the ECS in the human fetal testis from 6 to 17 developmental weeks and assessed the direct effects of phytocannabinoids Δ9-trans-tetrahydrocannabinol (THC) and cannabidiol (CBD) on the testis morphology and cell functions ex vivo. RESULTS: We demonstrate the presence in the human fetal testis of two key endocannabinoids, 2-arachidonylglycerol (2-AG) and to a lower level anandamide (AEA), as well as a range of enzymes and receptors for the ECS. Ex vivo exposure of first trimester testes to CBD, THC, or CBD/THC [ratio 1:1] at 10(−7) to 10(−5) M altered testosterone secretion by Leydig cells, AMH secretion by Sertoli cells, and impacted testicular cell proliferation and viability as early as 72 h post-exposure. Transcriptomic analysis on 72 h-exposed fetal testis explants revealed 187 differentially expressed genes (DEGs), including genes involved in steroid synthesis and toxic substance response. Depending on the molecules and testis age, highly deleterious effects of phytocannabinoid exposure were observed on testis tissue after 14 days, including Sertoli and germ cell death. CONCLUSIONS: Our study is the first to evidence the presence of the ECS in the human fetal testis and to highlight the potential adverse effect of cannabis consumption by pregnant women onto the development of the male gonad. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-023-02916-5. BioMed Central 2023-07-11 /pmc/articles/PMC10334520/ /pubmed/37430350 http://dx.doi.org/10.1186/s12916-023-02916-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Dochez-Arnault, J. Desdoits-Lethimonier, C. Matias, I. Evrard, B. Lagarrigue, M. Toupin, M. Lardenois, A. Chalmel, F. Mazaud-Guittot, S. Dejucq-Rainsford, N. Gely-Pernot, A. Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis |
title | Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis |
title_full | Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis |
title_fullStr | Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis |
title_full_unstemmed | Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis |
title_short | Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis |
title_sort | expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334520/ https://www.ncbi.nlm.nih.gov/pubmed/37430350 http://dx.doi.org/10.1186/s12916-023-02916-5 |
work_keys_str_mv | AT dochezarnaultj expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis AT desdoitslethimonierc expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis AT matiasi expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis AT evrardb expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis AT lagarriguem expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis AT toupinm expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis AT lardenoisa expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis AT chalmelf expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis AT mazaudguittots expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis AT dejucqrainsfordn expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis AT gelypernota expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis |